Lisa Maher

15.8k total citations · 2 hit papers
375 papers, 10.7k citations indexed

About

Lisa Maher is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lisa Maher has authored 375 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 291 papers in Epidemiology, 116 papers in Hepatology and 110 papers in Infectious Diseases. Recurrent topics in Lisa Maher's work include HIV, Drug Use, Sexual Risk (235 papers), Hepatitis C virus research (115 papers) and HIV/AIDS Research and Interventions (102 papers). Lisa Maher is often cited by papers focused on HIV, Drug Use, Sexual Risk (235 papers), Hepatitis C virus research (115 papers) and HIV/AIDS Research and Interventions (102 papers). Lisa Maher collaborates with scholars based in Australia, United States and Canada. Lisa Maher's co-authors include Jenny Iversen, John Kaldor, Gregory J. Dore, Libby Topp, Kimberly Page, Handan Wand, Kathleen Daly, Jason Grebely, David Dixon and Garrett Prestage and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Contemporary Sociology A Journal of Reviews.

In The Last Decade

Lisa Maher

361 papers receiving 10.2k citations

Hit Papers

Global burden of HIV, vir... 2016 2026 2019 2022 2016 2020 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lisa Maher 7.5k 3.1k 2.8k 2.7k 2.2k 375 10.7k
Tim Rhodes 10.3k 1.4× 5.8k 1.9× 1.8k 0.6× 4.1k 1.5× 3.1k 1.4× 264 13.2k
Josiah D. Rich 5.9k 0.8× 2.7k 0.9× 1.1k 0.4× 2.1k 0.8× 3.8k 1.7× 320 9.9k
Mark Tyndall 12.6k 1.7× 6.5k 2.1× 2.4k 0.9× 3.4k 1.3× 5.3k 2.4× 263 16.2k
Martin T. Schechter 8.5k 1.1× 5.8k 1.9× 925 0.3× 1.8k 0.7× 4.3k 1.9× 373 15.8k
Holly Hagan 8.2k 1.1× 3.8k 1.2× 4.4k 1.6× 1.2k 0.4× 1.9k 0.9× 190 9.7k
Peter Vickerman 11.4k 1.5× 5.5k 1.8× 5.6k 2.0× 1.9k 0.7× 2.8k 1.3× 394 14.6k
Frederick L. Altice 10.4k 1.4× 9.4k 3.1× 1.2k 0.4× 3.0k 1.1× 3.3k 1.5× 463 15.5k
Samuel R. Friedman 14.0k 1.9× 9.6k 3.1× 1.6k 0.6× 4.0k 1.5× 4.1k 1.9× 466 18.5k
Don C. Des Jarlais 16.1k 2.2× 9.8k 3.2× 4.0k 1.4× 3.5k 1.3× 5.0k 2.3× 525 21.6k
Kimberly Page 5.2k 0.7× 3.6k 1.2× 2.2k 0.8× 1.2k 0.5× 1.0k 0.5× 213 8.5k

Countries citing papers authored by Lisa Maher

Since Specialization
Citations

This map shows the geographic impact of Lisa Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Maher more than expected).

Fields of papers citing papers by Lisa Maher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Maher. The network helps show where Lisa Maher may publish in the future.

Co-authorship network of co-authors of Lisa Maher

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Maher. A scholar is included among the top collaborators of Lisa Maher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Maher. Lisa Maher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Price, Olivia, Lisa Maher, Amy Peacock, et al.. (2025). Changing age profile and incidence of injecting drug use initiation among people in Australia who inject drugs: evidence from two national repeated cross-sectional studies. The Lancet Regional Health - Western Pacific. 57. 101548–101548.
3.
Price, Olivia, Paul Dietze, Lisa Maher, et al.. (2024). High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs. Vaccine. 42(11). 2877–2885.
4.
McNeil, Ryan, et al.. (2024). ‘It just doesn't stop’: Perspectives of women who use drugs on increased overdoses during the COVID‐19 pandemic. Drug and Alcohol Review. 44(2). 602–612. 1 indexed citations
5.
Agius, Paul A., Bernadette Ward, Matthew Hickman, et al.. (2023). The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia. Addiction. 118(8). 1557–1568. 6 indexed citations
7.
Price, Olivia, Lisa Maher, Paul Dietze, et al.. (2023). COVID‐19 vaccine attitudes and facilitators among people in Australia who inject drugs. Drug and Alcohol Review. 42(5). 1066–1077. 2 indexed citations
8.
Hill, Penny, Mark Stoové, Paul A. Agius, et al.. (2022). Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study. Addiction. 117(12). 3091–3098. 4 indexed citations
9.
Price, Olivia, Paul Dietze, Lisa Maher, Sione Crawford, & Amy Peacock. (2022). COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews. Drug and Alcohol Review. 41(5). 1025–1028. 8 indexed citations
10.
Caruana, Theresa, et al.. (2022). Injection drug use in an affluent beachside community in Sydney: An exploratory qualitative study. Drug and Alcohol Review. 42(3). 544–554. 2 indexed citations
12.
Iversen, Jenny, Keith Sabin, Judy Chang, et al.. (2020). COVID‐19, HIV and key populations: cross‐cutting issues and the need for population‐specific responses. Journal of the International AIDS Society. 23(10). e25632–e25632. 60 indexed citations
13.
White, Bethany, et al.. (2019). Engaging people who inject drugs in hepatitis C virus testing and prevention through community‐based outreach, in Sydney, Australia. Drug and Alcohol Review. 38(2). 177–184. 10 indexed citations
14.
Sweeney, Sedona, Zoë Ward, Lucy Platt, et al.. (2019). Evaluating the cost‐effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs. Addiction. 114(3). 560–570. 22 indexed citations
15.
Lea, Toby, Mohamed Hammoud, Adam Bourne, et al.. (2019). Attitudes and Perceived Social Norms toward Drug Use among Gay and Bisexual Men in Australia. Substance Use & Misuse. 54(6). 944–954. 21 indexed citations
17.
Draughon, Jessica E., Adam W. Carrico, Jennifer L. Evans, et al.. (2016). The impact of violence on sex risk and drug use behaviors among women engaged in sex work in Phnom Penh, Cambodia. Drug and Alcohol Dependence. 161. 171–177. 36 indexed citations
18.
Mooney‐Somers, Julie, et al.. (2010). Learning from the past: young Indigenous people's accounts of blood-borne viral and sexually transmitted infections as resilience narratives. Culture Health & Sexuality. 13(2). 173–186. 21 indexed citations
19.
Higgs, Peter, Kei Owada, Margaret Hellard, Robert Power, & Lisa Maher. (2008). Gender, culture and harm: an exploratory study of female heroin users of Vietnamese ethnicity. Culture Health & Sexuality. 10(7). 681–695. 20 indexed citations
20.
Maher, Lisa, David Dixon, Michael T. Lynskey, & Wayne Hall. (1998). Running the risks: heroin, health and harm in South West Sydney. Peptides. 38. 1–140. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026